Skip to main content
SpringerLink
Log in

Animal Models of Integrated Serotoninergic Functions: Their Predictive Value for the Clinical Applicability of Drugs Interfering with Serotoninergic Transmission

  • Chapter
Serotoninergic Neurons and 5-HT Receptors in the CNS

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 129))

Abstract

Studies of serotonin in the brain began in the early 1950s, when Twarog and Page (1953) used a sensitive bioassay to detect the compound’s presence in cerebral tissue. Shortly afterwards, a possible central role for serotonin in mental illness was evoked by Wooley and Shaw (1954), based principally on the psychotomimetic activity of lysergic acid diethylamide (LSD), which had been found to antagonize the effects of serotonin on smooth muscle. Since this time, there has been an intense research effort towards an understanding of this neurotransmitter, and it is now clear that serotoninergic systems are implicated to various extents in the expression of a wide range of CNS functions, including neuronal development (Lauder 1983), thermoregulation (Feldberg and Myers 1964), pain (Tenen 1967), motor regulation (Jacobs 1991), sleep (Jouvet 1967), appetite (Fernstrom and Wurtman 1971), sexual behaviour (Gorzalka et al. 1990), aggression (Sheard 1969; Soubrié 1986), anxiety (Chopin and Briley 1987) and mood (Golden and Gilmore 1990).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ahlenius S, Larsson K (1984) Failure to antagonize the 8-hydroxy-2-(di-n-propylamino) tetralin-induced facilitation of male rat sexual behavior by the administration of 5-HT receptor antagonists. Eur J Pharmacol 99: 279–286

    Article  PubMed  CAS  Google Scholar 

  • Ahlenius S, Eriksson H, Larsson K, Modigh K, Sodersten P (1971) Mating behavior in the male rat treated with p-chlorophenylalanine methyl ester alone and in combination with pargyline. Psychopharmacologia 20: 383–388

    Article  PubMed  CAS  Google Scholar 

  • Ahlenius S, Larsson K, Svensson L (1980) Further evidence for an inhibitory role of central 5-HT in male rat sexual behavior. Psychopharmacology 68: 217–220

    Article  PubMed  CAS  Google Scholar 

  • Ahlenius S, Larsson K, Svensson L, Hjorth S, Carlsson A, Lindberg P, Wikstrom H, Sanchez D, Arvidsson LE, Hacksell U, Nilsson JLG (1981) Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacol Biochem Behav 15: 785–792

    Article  PubMed  CAS  Google Scholar 

  • Ahlenius S, Fernandez-Guasti A, Hjorth S, Larsson K (1986) Suppression of lordosis behaviour by the putative 5-HT receptor agonist 8-OH-DPAT in the rat. Eur J Pharmacol 124: 361–363

    Article  PubMed  CAS  Google Scholar 

  • Ananth J, Pecknold JC, Van der Steen N, Engelsmann F (1980) Double blind comparative study of clomipramine and amitryptliline in obsessive neurosis. Prog Neuropsychopharmacol Biol Psychiatry 5: 257–266

    Google Scholar 

  • Andrade R, Nicoll RA (1987) Pharmacological distinct actions of serotonin on single pyramidal neurons of the rat hippocampus recorded in vitro. J Physiol (Lond) 394: 99–124

    PubMed  CAS  Google Scholar 

  • Arnone M, Baroni M, Gai J, Guzzi U, Desclaux MF, Keane PE, Le Fur G, Soubrié P (1995) Effect of SR 59026A, a new 5-HT1A receptor agonist, on sexual activity in male rats. Behav Pharmacol 6: 276–282

    Article  PubMed  CAS  Google Scholar 

  • Ashby CR, Edwards E, Harkins KL, Wang RY (1989) Differential effect of typical and atypical antipsychotic drug on the suppressant action of 2-methyl-serotonin on medial prefrontal cortical cells: a microiontophoretic study. Eur J Pharmacol 166: 583–584

    Article  PubMed  CAS  Google Scholar 

  • Axelsson R, Nilsson A, Christensson E, Bjork R (1991) Effects of amperozide in schizophrenia: an open study of a potent 5-HT2 receptor antagonist. Psychopharmacology 104: 287–292

    Article  PubMed  CAS  Google Scholar 

  • Baldessarini RJ, Huston-Lyons D, Campbell A, Marsh E, Cohen BM (1992) Do central antiadrenergic actions contribute to the atypical properties of clozapine? Br J Psychiatry 17 (Suppl): 12–16

    Google Scholar 

  • Barr LC, Goodman WK, Price LH (1993) The serotonin hypothesis of obsessive compulsive disorder. Int Clin Psychopharmacol 8 (Suppl 2): 79–82

    Article  PubMed  Google Scholar 

  • Bendotti C, Samanin R (1986) 8-Hydroxy-(di-N-propylamino) tetralin (8-OH-DPAT) elicits eating in free feeding rats by acting on central serotonin neurons. Eur J Pharmacol 121: 147–154

    Article  PubMed  CAS  Google Scholar 

  • Bennett JP, Enna SF, Bylund DB, Gillin JC, Wyatt RJ, Snyder SH (1979) Neurotransmitter receptors in frontal cortices of schizophrenics. Arch Gen Psychiatry 36: 927–934

    Article  PubMed  CAS  Google Scholar 

  • Bentley KR, Barnes NM (1995) Therapeutic potential of serotonin 5-HT3 antagonists in neuropsychiatric disorders. CNS Drugs 3: 363–392

    Article  Google Scholar 

  • Berendsen HG, Jenck F, Broekkamp CLE (1990) Involvement of 5-HT1C receptors in drug-induced penile erections in rats. Psychopharmacology 101: 57–61

    Article  PubMed  CAS  Google Scholar 

  • Blaha CD, Lane RF (1987) Chronic treatment with classical and atypical antipsychotic drug differentially decreases dopamine release in striatum and nucleus accumbens in vivo. Neurosci Lett 78: 199–204

    Article  PubMed  CAS  Google Scholar 

  • Blier P, De Montigny C (1990) Differential effect of gepirone on presynaptic and postsynaptic serotonin receptors: single-cell recording studies. J Clin Psychopharmacol 10: 135–209

    Article  Google Scholar 

  • Blundell JE, Leshem MB (1974) Central action of anorexic agents: effects of amphetamine and fenfluramine in rats with lateral hypothalamic lesions. Eur J Pharmacol 28: 81–88

    Article  PubMed  CAS  Google Scholar 

  • Borison RL, Diamond BI (1983) Regional selectivity of neuroleptic drugs: an argument for site specificity. Brain Res Bull 11: 215–218

    Article  PubMed  CAS  Google Scholar 

  • Borsini F, Meli A (1988) Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 94: 147–160

    Article  PubMed  CAS  Google Scholar 

  • Broekkamp CLE, Berendsen HHE, Jenck F, Van Delft AML (1989) Animal models for anxiety and response to serotonergic drugs. Psychopathology 22 (Suppl 1): 2–12

    Article  PubMed  Google Scholar 

  • Cervo L, Samanin R (1987) Potential antidepressant properties of 8-OH-DPAT, a selective serotonin-1A receptor agonist. Eur J Pharmacol 144: 223–229

    Article  PubMed  CAS  Google Scholar 

  • Cervo L, Grignaschi G, Samanin R (1988) 8-OH-DPAT, a selective serotonin-1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis. Eur J Pharmacol 158: 53–59

    Article  PubMed  CAS  Google Scholar 

  • Chiodo LA, Bunney BS (1983) Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci 3: 1607–1619

    PubMed  CAS  Google Scholar 

  • Chiodo LA, Bunney BS (1985) Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons. J Neurosci 5: 2539–2544

    PubMed  CAS  Google Scholar 

  • Chopin P, Briley M (1987) Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmission. Trends Pharmacol Sci 8: 383–388

    Article  CAS  Google Scholar 

  • Costall B, Domeney AM, Naylor RJ, Tyers MB (1987) Effects of the 5-HT3 receptor antagonist GR38032F on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain. Br J Pharmacol 92: 881–894

    Article  PubMed  CAS  Google Scholar 

  • Costall B, Kelly ME, Naylor RJ, Onaivi ES (1988a) Actions of buspirone in a putative model of anxiety in the mouse. J Pharm Pharmacol 40: 494–500

    Article  PubMed  CAS  Google Scholar 

  • Costall B, Domeney AM, Gerrard PA, Kelly ME, Naylor RJ, Tyers MB (1988b) Zacopride: anxiolytic profile in rodent and primate models of anxiety. J Pharm Pharmacol 40: 302–305

    Article  PubMed  CAS  Google Scholar 

  • Costall B, Naylor RJ, Tyers MB (1990) The psychopharmacology of 5-HT3 receptors. Pharmacol Ther 47: 1816–202

    Article  Google Scholar 

  • Crow TJ, Baker H, Gross A, Josephy M, Lofthouse R, Longden A, Owen F, Riley G, Glover V, Killpack W (1979) Monamine mechanisms in chronic schizophrenia: post-mortem neurochemical findings. Br J Psychiatry 134: 249–256

    Article  PubMed  CAS  Google Scholar 

  • Dourish CT, Hutson PH, Curzon G (1985) Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology 86: 197–204

    Article  PubMed  CAS  Google Scholar 

  • Dourish CT, Hutson PH, Curzon G (1986) Para-chlorophenylalanine prevents feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH- DPAT). Psychopharmacology 89: 467–471

    Article  PubMed  CAS  Google Scholar 

  • Edwards E, Ashby CR Jr, Wang RY (1991) The effect of typical and atypical antipsychotic drugs on the stimulation of phosphoinositide hydrolysis produced by the 5-HT3 receptor agonist 2-methyl-serotonin. Brain Res 545: 276–278

    Article  PubMed  CAS  Google Scholar 

  • Farley I, Shannak K, Hornykiewicz O (1980) Brain monoamine changes in chronic paranoid schizophrenia and their possible relation to increased dopamine receptor sensitivity. In: Pepeu G, Kuhar M, Enna S (eds) Receptors for neurotransmitters and peptide hormones. Raven Press, New York, pp 427–433

    Google Scholar 

  • Feldberg W, Myers RD (1964) Effects on temperature of 5-hydroxytryptamine, adrenaline and noradrenaline injected into the cerebral ventricles or the hypothalamus of cats. J Physiol (Lond) 173: 25

    Google Scholar 

  • Ferguson JM, Feighner JP (1987) Fluoxetine-induced weight loss in overweight non-depressed humans. Int J Obes 11 (Suppl 3): 163–170

    PubMed  Google Scholar 

  • Fernandez-Guasti A, Escalante A, Agmo A (1989) Inhibitory action of various 5-HT1B receptor agonists on rat masculine sexual behavior. Pharmacol Biochem Behav 34: 811–816

    Article  PubMed  CAS  Google Scholar 

  • Fernstrom JD, Wurtman RJ (1971) Brain serotonin content: increase following ingestion of carbohydrate diet. Science 174: 1023–1025

    Article  PubMed  CAS  Google Scholar 

  • File SE, Johnston AL (1989) Lack of effects of 5-HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat. Psychopharmacology 99: 248–251

    Article  PubMed  CAS  Google Scholar 

  • Fink H, Morgenstern R, Oetssner W (1984) Clozapine — A serotonin antagonist? Pharmacol Biochem Behav 20: 513–517

    Article  PubMed  CAS  Google Scholar 

  • Foa EB, Steketee G, Kozak MJ, Dugger D (1987) Imipramine and placebo in the treatment of obsessive compulsives: their effect on depression and on obsessional symptoms. Psychopharmacol Bull 23: 8–11

    PubMed  CAS  Google Scholar 

  • Freeman CP, Hampson M (1987) Fluoxetine as a treatment for bulimia nervosa. Int J Obes 11 (Suppl 3): 171–177

    PubMed  Google Scholar 

  • Friedman RL, Sanders-Bush E, Barrett RL (1985) Clozapine blocks disruptive and discriminative stimulus effects of quipazine. Eur J Pharmacol 106: 191–193

    Article  Google Scholar 

  • Gaddum JH (1954) Drugs antagonistic to 5-hydroxytryptamine. In: Wolstenholme GW (ed) Ciba Foundation Symposium on Hypertension. Little Brown and Company, Boston, pp 75–77

    Google Scholar 

  • Gelders Y, Ceulemans DY, Hoppenbrouwers ML, Reyntjens A, Janssen P (1985) Ritanserin, a selective serotonin antagonist in chronic schizophrenia. In: IVth World Congress of Biological Psychiatry. Abstract 420.4, p 338

    Google Scholar 

  • Geller I, Blum K (1970) The effect of 5-HTP on para-chlorophenylalanine (p-CPA) attenuation of conflict behaviour. Eur J Pharmacol 9: 319–324

    Article  PubMed  CAS  Google Scholar 

  • Geretsegger C, Greimel KV, Roed IS, Hesselink JMK (1995) Ipsapirone in the treatment of bulimia nervosa — an open pilot study. Int J Eating Disorders 17: 359–363

    Article  CAS  Google Scholar 

  • Gilbert F, Dourish CT (1987) Effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by 8-OH-DPAT. Psychopharmacology 93: 349–352

    Article  PubMed  CAS  Google Scholar 

  • Giral P, Martin P, Soubrié P, Simon P (1988) Reversal of helpless behaviour in rats by putative 5-HT1A agonists. Biol Psychiatry 23: 237–242

    Article  PubMed  CAS  Google Scholar 

  • Goldberg HL, Finnerty RJ (1979) The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Am J Psychiatry 136: 1184–1187

    PubMed  CAS  Google Scholar 

  • Golden RN, Gilmore J (1990) Serotonin and mood disorder. Psychatr Ann 20: 580–586

    Google Scholar 

  • Goodman WK, Price LH, Delgado DL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger GR, Charney DS (1990) Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 47: 577–585

    Article  PubMed  CAS  Google Scholar 

  • Gorzalka BB, Mendelson SD, Watson NV (1990) Serotonin receptor subtypes and sexual behavior. Ann NY Acad Sci 600: 435–446

    Article  PubMed  CAS  Google Scholar 

  • Goudie AJ, Thomton EW, Wheeler TJ (1976) Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and on 5-hydroxytryptophan-induced anorexia. Evidence for serotonergic inhibition of feeding. J Pharm Pharmacol 28: 318–320

    Article  PubMed  CAS  Google Scholar 

  • Griebel G (1995) 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol Ther 65: 319–395

    Article  PubMed  CAS  Google Scholar 

  • Hamon M, Fattacini CM, Adrien J, Gallissot MC, Martin P, Gozlan H (1988) Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties. J Pharmacol Exp Ther 246: 745–752

    PubMed  CAS  Google Scholar 

  • Hand TH, Hu XT, Wang RY (1987) Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons. Brain Res 415: 259–269

    Article  Google Scholar 

  • Heller AH, Beneke M, Kuemmel B, Spencer D, Kurtz NM (1990) Ipsapirone: evidence for efficacy in depression. Psychopharmacol Bull 26: 219–222

    PubMed  CAS  Google Scholar 

  • Hewson G, Leighton GE, Hill RG, Hughes J (1988) Ketanserin antagonises the anorectic effect of dl-fenfluramine in the rat. Eur J Pharmacol 145: 227–230

    Article  PubMed  CAS  Google Scholar 

  • Hillegaart V, Ahlenius S, Larsson K (1989) Effects of local application of 5-HT into the median and dorsal raphe nuclei on male rat sexual and motor behaviour. Behav Brain Res 33: 279–286

    Article  PubMed  CAS  Google Scholar 

  • Hillegaart V, Ahlenius S, Larsson K (1991) Region-selective inhibition of male rat sexual behaviour and motor performance by localised forebrain 5-HT injections: a comparison with effects produced by 8-OH-DPAT. Behav Brain Res 42: 169–180

    Article  PubMed  CAS  Google Scholar 

  • Hollander E, De Carin C, Gully R, Nitescu A, Suckow RF, Gorman JM, Klein DF, Liebowitz MR (1991) Effects of chronic fluoxetine treatment on behavioural and neuroendocrine responses to methachlorophenylpiperazine. Psychiatr Res 36: 1–17

    Article  CAS  Google Scholar 

  • Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA (1994) International Union of Pharmacology Classification of Receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46: 157–204

    PubMed  CAS  Google Scholar 

  • Hutson PH, Dourish CT, Curzon G (1986) Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors. Eur J Pharmacol 129: 347–352

    Article  PubMed  CAS  Google Scholar 

  • Hutson PH, Donohoe TP, Curzon G (1987) Neurochemical and behavioural evidence for an agonist action of 1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)- piperazine (LY 165163) at central 5-HT receptors. Eur J Pharmacol 138: 215–223

    Article  PubMed  CAS  Google Scholar 

  • Hutson PH, Donohoe TP, Curzon G (1988) Infusion of the 5-hydroxytryptamine agonists RU 24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia. Psychopharmacology 95: 550–552

    Article  PubMed  CAS  Google Scholar 

  • Hutson PH, Sarna GS, O’Connell MT, Curzon G (1989) Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OH-DPAT into the nucleus raphe dorsalis. Neurosci Lett 100: 276–280

    Article  PubMed  CAS  Google Scholar 

  • Insel TR, Zohar J, Berkelfat C, Murphy D (1990) Serotonin in obsessions, compulsions and the control of aggressive impulses. Ann NY Acad Sci 600: 547–586

    Article  Google Scholar 

  • Jacobs BL (1991) Serotonin and behaviour: emphasis on motor control. J Clin Psychiatry 52 (Suppl): 17–23

    PubMed  Google Scholar 

  • Jenck F, Moreau JL, Mutel V, Martin JR, Haefely WE (1993) Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs. Eur J Pharmacol 231: 223–229

    Article  PubMed  CAS  Google Scholar 

  • Jones BJ, Costall B, Domeney AM, Kelly ME, Naylor RJ, Oakley NR, Tyers MB (1988) The potential anxiolytic activity of GR 38032F, a 5-HT3 receptor antagonist. Br J Pharmacol 93: 985–993

    Article  PubMed  CAS  Google Scholar 

  • Jouvet M (1967) Neurophysiology of the states of sleep. Physiol Rev 47: 117–177

    PubMed  CAS  Google Scholar 

  • Kennett GA, Curzon G (1988) Evidence that mCPP may have behavioural effects mediated by 5-HT1C receptors. Br J Pharmacol 94: 137–147

    Article  PubMed  CAS  Google Scholar 

  • Kennett GA, Dourish CT, Curzon G (1987) 5-HT1B agonists induce anorexia at a postsynaptic site. Eur J Pharmacol (Netherlands) 141: 429–435

    Article  PubMed  CAS  Google Scholar 

  • Kennett GA, Lightlower S, De Biasi V, Stevens NC, Wood MD, Tulloch IF, Blackburn TP (1994) Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT2C/2B receptor function. Neuropharmacology 33: 1581–1588

    Article  PubMed  CAS  Google Scholar 

  • Kilpatrick GJ, Jones BJ, Tyers MB (1987) Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature 330: 746–748

    Article  PubMed  CAS  Google Scholar 

  • Kline MD (1989) Fluoxetine and anorgasmia. Am J Psychiatry 146: 804–805

    PubMed  CAS  Google Scholar 

  • Kuoppamaki M, Seppala T, Syvalahti E, Hietala J (1993) Chronic clozapine treatment decreases 5-hydroxytryptamine1C receptor density in the rat choroid plexus: comparison with haloperidol. J Pharmacol Exp Ther 264: 1262–1267

    PubMed  CAS  Google Scholar 

  • Lauder JM (1983) Hormonal and humoral influences on brain development. Psychoneuroendocrinology 8: 121–155

    Article  PubMed  CAS  Google Scholar 

  • Leibowitz SF, Shor-Posner G (1986) Brain serotonin and eating behavior. Appetite 7 (Suppl): 1–14

    Article  PubMed  CAS  Google Scholar 

  • Marek G, Li A, Seiden L (1989) Selective 5-hydroxytryptamine2 antagonists have antidepressant-like effects on differential-reinforcement-of-low-rate 72-second schedule. J Pharmacol Exp Ther 250: 52–59

    PubMed  CAS  Google Scholar 

  • Martin P, Beninger RJ, Hamon M, Puech AJ (1990) Antidepressant-like action of 8-OH-DPAT, a 5-HT1A agonist, in the learned helplessness paradigm: evidence for a postsynaptic mechanism. Behav Brain Res 38: 135–140

    Article  PubMed  CAS  Google Scholar 

  • Martin P, Gozlan H, Puech AJ. (1992) 5-HT3 receptor antagonists reverse helpless behaviour in rats. Eur J Pharmacol 212: 73–78

    Article  PubMed  CAS  Google Scholar 

  • Meltzer HY (1989) Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology 99: S18-S27

    Article  PubMed  Google Scholar 

  • Meltzer HY (1992) The importance of serotonin-dopamine interactions in the action of clozapine. Br J Psychatry 17 (Suppl): 22–29

    Google Scholar 

  • Meltzer HY (1994) An overview of the mechanism of action of clozapine. J Clin Psychiatry 55 (Suppl B): 47–52

    PubMed  Google Scholar 

  • Mendels J, Camera A, Sikes C (1995) Sertraline treatment for premature ejaculation. J Clin Psychopharmacol 15: 341–346

    Article  PubMed  CAS  Google Scholar 

  • Mendelson SD, Gorzalka BB (1985) Serotonin antagonist piremperone inhibits sexual behavior in the male rat: attenuation by quipazine. Pharmacol Biochem Behav 22: 565–571

    Article  PubMed  CAS  Google Scholar 

  • Mendelson SD, Gorzalka BB (1986) Methysergide inhibits and facilitates lordosis behaviour in the female rat in a time-dependent manner. Neuropharmacol 25: 749–755

    Article  CAS  Google Scholar 

  • Mendelson SD, Gorzalka BB (1990) Sex differences in the effects of 1-(m-trifluoromethylphenyl) piperazine and 1-(m-chlorophenyl) piperazine on copulatory behavior in the rat. Neuropharmacol 29: 783–786

    Article  CAS  Google Scholar 

  • Meyerson BJ (1964) Estrus behaviour in spayed rats after estrogen or progesterone treatment in combination with reserpine or tetrabenazine. Psychopharmacologia 6: 210–218

    Article  PubMed  CAS  Google Scholar 

  • Mos J, Olivier B (1991) On the site of action of eltoprazine, TFMPP and 8-OH-DPAT in reducing aggression in rats. Biol Psychiatry 29: 209S

    Google Scholar 

  • Neill JC, Cooper SJ (1988) Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors. Psychopharmacology 97: 213–218

    Article  Google Scholar 

  • Olivier B, Mos J (1992) Rodent models of aggressive behaviour and serotonergic drugs. Prog Neuropsychopharmacol Biol Psychiatry 16: 847–870

    Article  PubMed  CAS  Google Scholar 

  • Olivier B, Mos J (1986) Serenics and aggression. Stress Med 2: 197–209

    Article  Google Scholar 

  • Olivier B, Mos J, Van der Heyden JAM, Hertoz J (1989) Serotonergic modulation of social interactions in isolated male mice. Psychopharmacology 97: 154–156

    Article  PubMed  CAS  Google Scholar 

  • Othmer E, Othmer SC (1987) Effect of buspirone on sexual dysfunction in patients with generalised anxiety disorder. J Clin Psychiatry 48: 201–203

    PubMed  CAS  Google Scholar 

  • Peroutka SJ, Snyder SH (1980) Long-term antidepressant treatment decreases spiroperidol-labelled serotonin receptor binding. Science 210: 956–962

    Article  Google Scholar 

  • Pinder RM, Wieringa JH (1993) Third generation antidepressants. Med Res Rev 13: 259–325

    Article  PubMed  CAS  Google Scholar 

  • Pomerantz SM, Hepner BC, Wertz JM (1993) 5-HT1A and 5-HT1C/1D receptor agonists produce reciprocal effects on male sexual behavior of rhesus monkeys. Eur J Pharmacol 243: 227–234

    Article  PubMed  CAS  Google Scholar 

  • Poncelet M, Pério A, Simiand J, Gout G, Soubrié P, Le Fur G (1995) Antidepressantlike effects of SR 57227A, a 5-HT3 receptor agonist, in rodents. J Neural Transm (in press)

    Google Scholar 

  • Porsolt RD (1991) Pharmacological models of depression. In: Olivier B, Mos J, Slangen JL (eds) Animal models in psychopharmacology. Birkhaüser-Verlag, Basel, pp 137–160

    Google Scholar 

  • Rasmussen K, Aghajanian GK (1988) Potency of antipsychotics in reversing the effects of a hallucinogenic drug on locus coeruleus neurons correlates with compound binding affinity. Neuropsychopharmacology 1: 101–107

    Article  PubMed  CAS  Google Scholar 

  • Ratey JJ, Chandler HK (1995) Serenics. Therapeutic potential in aggression. CNS Drugs 4: 256–260

    Article  Google Scholar 

  • Reynolds GP, Rossor MN, Iversen LL (1983) Preliminary studies of human cortical 5-HT2 receptors and their involvement in schizophrenia and neuroleptic drug action. J Neural Transm 18 (Suppl): 273–277

    CAS  Google Scholar 

  • Rickels K, Amsterdam JD, Clary C, Puzzuoli G, Schweitzer E (1991) Buspirone in major depression: a controlled study. J Clin Psychiatry 52: 34–38

    PubMed  CAS  Google Scholar 

  • Rinaldi-Carmona M, Congy C, Santucci V, Simiand J, Gautrel B, Neliat G, Labeeuw B, Le Fur G, Soubrié P, Brelière JC (1992) Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytriptamine2 receptor antagonist. J Pharmacol Exp Ther 262: 759–768

    PubMed  CAS  Google Scholar 

  • Rivest R, Jolicoeur FB, Marsden CA (1991) Use of amfonelic acid to discriminate between classical and atypical neuroleptics and neurotensin: an in vivo voltammetric study. Brain Res 544: 86–93

    Article  PubMed  CAS  Google Scholar 

  • Robinson PH, Checkley SA, Russel GFM (1985) Suppression of eating by fenfluramine in patients with bulimia nervosa. Br J Psychiatry 146: 169–176

    Article  PubMed  CAS  Google Scholar 

  • Samanin R, Mennini T, Ferraris A, Bendotti C, Borsini F, Garaltini S (1979) m-Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats. Naunyn Schmiedebergs Arch Pharmacol 308: 159–163

    Article  PubMed  CAS  Google Scholar 

  • Sheard MH (1969) The effect of pCPA on behavior in rats: relation to brain serotonin and 5-HIAA. Brain Res 15: 524–528

    Article  PubMed  CAS  Google Scholar 

  • Shillito EE (1969) The effect of p-chlorophenylalanine on social interactions of male rats. Br J Pharmacol 36: 193–194

    Google Scholar 

  • Sijbesma H, Schipper J, De Kloet ER, Mos J, Van Aken H, Olivier B (1991) Postsynaptic 5-HT1 receptors and offensive aggression in rats: a combined behavioural and autoradiographic study with eltoprazin. Pharmacol Biochem Behav 38: 447–458

    Article  PubMed  CAS  Google Scholar 

  • Simiand J, Keane PE, Barnouin MC, Keane M, Soubrié P, Le Fur G (1993) Neuropsychopharmacological profile in rodents of SR 57746A, a new, potent 5-HT1A receptor agonist. Fund Clin Pharmacol 7: 413–427

    CAS  Google Scholar 

  • Sorensen SM, Kehne JH, Fadayel GM, Humphreys TM, Ketteler HJ, Sullivan CK, Taylor VL, Schmidt CJ (1993) Characterization of the 5-HT2 receptor antagonist MDL 100, 907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies. J Pharmacol Exp Ther 266: 684–691

    PubMed  CAS  Google Scholar 

  • Soubrié P (1986) Reconciling the role of central serotonin neurons in human and animal behavior. Behav Brain Res 9: 319–364

    Article  Google Scholar 

  • Sprouse JS, Aghajanian GK (1986) (-)-Propranolol blocks the inhibition of serotonergic dorsal raphe firing by 5-HT1A selective agonists. Eur J Pharmacol 128: 295–298

    Article  PubMed  CAS  Google Scholar 

  • Sprouse JS, Aghajanian GK (1987) Electrophysiological responses of serotonergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse 1: 3–9

    Article  PubMed  CAS  Google Scholar 

  • Stein DJ, Wise CD, Berger BD (1973) Anti-anxiety action of benzodiazepines: decrease in activity of serotonin neurons in the punishment system. In: Costa E, Greengard P (eds) The benzodiazepines. Raven Press, New York, pp 299–326

    Google Scholar 

  • Stewart IC, Dopald P, Munro JF (1986) Neuropharmacological treatment of obesity. In: Ferrari E, Brambilla F (eds) Disorders of eating behaviour: a psychoneuroendocrine approach. Pergamon Press, Oxford, pp 295–303

    Google Scholar 

  • Szara S (1967) Hallucinogenic amines and schizophrenia. In: Himwich HE, Kety SS, Snythies JR (eds) Amines and schizophrenia. Pergamon Press, New York, pp 181–197

    Google Scholar 

  • Tenen SS (1967) The effects of p-chlorophenylalanine, a serotonin depletor, on avoidance acquisition, pain sensitivity and related behaviour in the rat. Psychopharmacology 10: 204–219

    Article  CAS  Google Scholar 

  • Thiébot MH, Soubrié P, Hamon M, Simon P (1984) Evidence against the involvement of serotonergic neurons in the anti-punishment activity of diazepam in the rat. Psychopharmacology 182: 355–359

    Article  Google Scholar 

  • Traber J, Glaser T (1987) 5-HT1A receptor-related anxiolytics. Trends Pharmacol Sci 8: 432–437

    Article  CAS  Google Scholar 

  • Twarog BM, Page JH (1953) Serotonin content of some mammalian tissues and urine and a method of its determination. Am J Physiol 175: 157–161

    PubMed  CAS  Google Scholar 

  • Volonte M, Ceci A, Borsini F (1992) Effect of haloperidol and clozapine on (+) SKF 10047-induced dopamine release: role of 5-HT3 receptors. Eur J Pharmacol 213: 163–164

    Article  PubMed  CAS  Google Scholar 

  • Waldbillig RJ (1979) The role of the dorsal and median raphe in the inhibition of muricide. Brain Res 160: 341–346

    Article  PubMed  CAS  Google Scholar 

  • Wang RY, Ashby CR, Edwards E, Zhang JY (1994) The role of 5-HT3-like receptors in the action of clozapine. J Clin Psychiatry 55 (Suppl B): 23–26

    PubMed  Google Scholar 

  • White SM, Kucharik RF, Moyer JA (1991) Effects of serotonergic agents on isolation-induced aggression. Pharmacol Biochem Behav 39: 729–736

    Article  PubMed  CAS  Google Scholar 

  • Willner P (1991) Behavioural models in psychopharmacology. Cambridge University Press, Cambridge

    Google Scholar 

  • Woods A, Smith C, Szewczak M, Dunn RW, Comfeldt M, Borbett R (1993) Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder. Psychopharmacology 112: 195–198

    Article  PubMed  CAS  Google Scholar 

  • Wooley DM, Shaw E (1954) A biochemical and pharmacological suggestion about certain mental disorders. Proc Natl Acad Sci 40: 228–231

    Article  Google Scholar 

  • Yadin E, Friedman E, Wagner HB (1991) Spontaneous alternation behavior: an animal model for obsessive-compulsive disorder? Pharmacol Biochem Behav 40: 311–315

    Article  PubMed  CAS  Google Scholar 

  • Zajecka J, Fawcett F, Schaff M, Jeffries H, Guy C (1991) The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction. J Clin Psychiatry 52: 66–68

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. P. E. Keane
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Soubrié
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Freie Universität Berlin, Institut für Anatomie, Königin-Luise-Str. 15, 14195, Berlin, Germany

    H. G. Baumgarten M.D.

  2. Rheinische Friedrich-Wilhelms-Universität Bonn, Institut für Pharmakologie und Toxikologie, Reuterstr. 2b, 53113, Bonn, Germany

    M. Göthert

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Keane, P.E., Soubrié, P. (2000). Animal Models of Integrated Serotoninergic Functions: Their Predictive Value for the Clinical Applicability of Drugs Interfering with Serotoninergic Transmission. In: Baumgarten, H.G., Göthert, M. (eds) Serotoninergic Neurons and 5-HT Receptors in the CNS. Handbook of Experimental Pharmacology, vol 129. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60921-3_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60921-3_27

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-66715-5

  • Online ISBN: 978-3-642-60921-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation